(1) The rate of response to chemotherapy probably depends on the doubling time of the malignant cells. In advanced generalized malignant disease (i.e. approximately 1012 malignant cells in body) the doubling time is low, because the tumour growth fraction is reduced and the intermitotic time is increased. That is, with advancing disease, a progressively smaller proportion of the patient's malignant cells are vulnerable to phase-specific drug attack (Bagshawe 1968) . In addition, these conditions may permit repair of CPA-induced DNA damage before the affected cell reaches its next mitosis: under these circumstances CPA is acting in effect as a phase-specific agent, thus reducing its value as the best of the single agents for breast cancer.
(2) The ratio of tumour cell bulk to surviving bone marrow may be too great. This is most likely to be so with carcinoma of the breast in which the marrow is frequently infiltrated with cancer cells and may have been extensively irradiated.
Our increasing confidence in the efficacy of combination chemotherapy in breast cancer has led to its gradual movement up the order of precedence of palliative treatments for many cases of disseminated disease, and for some cases of regional disease. The response to chemotherapy is at least twice as high as that to hormonal therapy. It is therefore no longer justified to submit a steadily deteriorating patient to a succession of different hormonal approaches (each for the relatively long period required to ascertain its lack of effectiveness) and to consider her for chemotherapy only when she has reached that state in which she is least likely to benefit from it. Large future series will show whether unorthodox early treatment with chemotherapy alters, the probability oflater response to hormonal therapy: if it is shown that it does not reduce it, then this will further advance the case for early consideration of chemotherapy. Relapse in bone or progression of bony metastases in patients who are otherwise responders to chemotherapy has been noted in several reports: in our series, 2 such patients who were submitted to adrenalectomy benefited from it. (Abercrombie & Ambrose 1962) , loss of densitydependent inhibition of growth (Stoker & Rubin 1967) , changes in the cell surface (Burger 1971) , and changes in response to environmental signals. One expression of the latter alteration is a reduced requirement for serum (Clarke & Stoker 1971 , Holley & Kiernan 1971 , Dulbecco 1970 .
The cell cycle is conventionally divided into four phases (Howard & Pelc 1953) . Mitosis (M) is followed by a gap (G1 phase), then a period of DNA synthesis (S phase) and a second gap (G2 phase) preceding the next mitosis. When normal BHK cells are placed in a medium containing low serum concentrations (0.5 %), they become quiescent in the Gi phase of the cell cycle after a period of hours (Burk 1967) . In contrast, PyBHK cells in low or no serum continue to enter S phase but die after 24-48 hours in culture (Clarke & Stoker 1971 One explanation for these observations is that in the absence of serum PyBHK cells have a generally expanded cell cycle. To test this explanation of the behaviour of PyBHK cells, rates of synthesis of DNA, and rates of entry of cells into mitosis in the absence of serum were studied. These were both found to be reduced when compared with cells in high serum. As the percentage of cells in S phase is equal with and without serum, the rate of progress of PyBHK through S in the absence of serum must be reduced. That is, the S phase of transformed cells is expanded in the absence of serum. In contrast, when normal cells are grown under conditions in which their growth rate is reduced, the expansion of the cell cycle is due to an expansion of G1 (Prescott 1968 
